ARCHIVES

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

This article is from The Cancer Letter archive.

Vol. 18 No. 17 | April 25, 1992

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979